1. A Facile Fluorometric Assay of Orotate Phosphoribosyltransferase Activity Using a Selective Fluorogenic Reaction for Orotic Acid
   Takayuki Shibata et al, 2023, Sensors CrossRef
2. Determination of thymidine phosphorylase expression level facilitates recurrence risk stratification in stage II/III colorectal cancer following adjuvant chemotherapy with oral fluoropyrimidines
   Naruji Kugimiya et al, 2019, Oncology Letters CrossRef
3. Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
   Helen Winter et al, 2019, Cancers CrossRef
4. Impact of primary tumor location as a predictive factor in patients suffering from colorectal cancer treated with cytotoxic anticancer agents based on the collagen gel droplet‑embedded drug sensitivity test
   Takumi Ochiai et al, 2018, Oncology Letters CrossRef
5. Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
   Andrea Botticelli et al, 2016, PLOS ONE CrossRef
6. The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis
   Xiaojun Sun et al, 2020, Pathology & Oncology Research CrossRef
7. 5-Fluorouracil degradation rate could predict toxicity in stages II–III colorectal cancer patients undergoing adjuvant FOLFOX
   Concetta E. Onesti et al, 2017, Anti-Cancer Drugs CrossRef
8. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer
   Dongdong Luo et al, 2021, European Journal of Medicinal Chemistry CrossRef
9. Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
   Pan Xie et al, 2020, Cellular Oncology CrossRef
10. Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort
    Federica Mazzuca et al, 2016, Oncotarget CrossRef
11. Novel ProTide prodrugs of 5-fluoro-2′-deoxyuridine for the treatment of liver cancer
    Leilei Jiang et al, 2023, European Journal of Medicinal Chemistry CrossRef
12. Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
    Marina Borro et al, 2017, Oncotarget CrossRef
13. Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer
    Adarsh Kumar et al, 2022, Medical Oncology CrossRef
14. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer
    Chong Ma et al, 2018, Pathology - Research and Practice CrossRef
15. Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
    Nikolaos Tsesmetzis et al, 2018, Cancers CrossRef